MEDICA and COMPAMED 2020 to be launched as 'virtual.MEDICA' and 'virtual.COMPAMED' with three focal areas
MEDICA 2020 and COMPAMED 2020, the world-leading information and communication platforms for the medical technology industry and supplier industry for the medical technology industry, will take place entirely online from 16 to 19 November 2020. Within the framework of 'virtual.MEDICA' and 'virtual.COMPAMED', decision-makers from all sectors of the healthcare industry can then expect a comprehensive range of products and services at https://virtual.medica.de and https://virtual.compamed.de consisting of three focal areas: The Conference Area (conference and forum program), the Exhibition Space (for exhibitors and product innovations) and theNetworking Plaza (networking/ matchmaking).
"Our hygiene and infection protection plan was positively received by the exhibitors and the successive relaxations of the international travel rules in early summer meant that we had realistic hopes that both trade fairs would be able to be held successfully and safely. The development of the global pandemic must now, however, be re-evaluated. Against the backdrop of a multitude of travel limitations and considering the very international demographic of MEDICA and COMPAMED in terms of both exhibitors and visitors, we must now focus solely on the virtual format this year", explains Wolfram Diener, Chairman and CEO of Messe Düsseldorf. "The essence of the MEDICA and COMPAMED brand is global broadcasting for exhibitors and visitors. This central core is still present this year, just not in the form of an event that demands physical presence, due to the pandemic. With our comprehensive virtual marketplace and high-profile program elements, we are laying the foundations now to gain a joint headstart in 2021, in line with the situation", says Wolfram Diener.
Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep and less daytime sleepiness when sleeping with a weighted chain blanket.
Researchers at Karolinska Institutet have developed a method for fast, cheap, yet accurate testing for COVID-19 infection. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics. This makes the method particularly attractive for places and situations with limited resources.
Indiana University School of Medicine researchers are learning more about ways to prevent infections in women with obesity who have cesarean delivery. The multi-site study revealed using prophylactic negative pressure wound therapy (NPWT) does not appear to lower the risk of infection for this high-risk group.
This study is one of the first, if not the first, prospective, randomized, interventional clinical trials of near-infrared, low-level light therapy (LLLT) in patients who recently suffered a moderate brain injury. If further trials support these findings, light therapy could become the first widely-accepted treatment for this type of injury.
A dose of artificial intelligence can speed the development of 3D-printed bioscaffolds that help injuries heal, according to researchers at Rice University. A team led by computer scientist Lydia Kavraki of Rice's Brown School of Engineering used a machine learning approach to predict the quality of scaffold materials, given the printing parameters.
Researchers at the University of Pittsburgh School of Medicine and Carnegie Mellon University College of Engineering have created a machine-learning algorithm that can detect subtle signs of osteoarthritis - too abstract to register in the eye of a trained radiologist - on an MRI scan taken years before symptoms even begin.
Despite the important advances in research in recent years, the etiopathogenesis of Alzheimer's disease is still not fully clarified. One of the key questions is to decipher why the production of beta amyloid, the protein that produces the toxic effect and triggers the pathology, increases in the brain of people with Alzheimer's.
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer.
A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal COVID-19 antibody test. The multicenter collaboration tested alternative ways to measure COVID-19 antibody levels that is faster and easier.
Face masks have become an important tool in fighting against the COVID-19 pandemic. However, improper use or disposal of masks may lead to "secondary transmission". A research team from City University of Hong Kong (CityU) has successfully produced graphene masks with an anti-bacterial efficiency of 80%, which can be enhanced to almost 100% with exposure to sunlight for around 10 minutes.
Employee safety is patient safety – this becomes clearer than ever during the Corona pandemic. It is not only about preventing infection, but also about protection from physical and mental stress. This will be highlighted on 17 September 2020 on the occasion of World Patient Safety Day.
According to ARRS' American Journal of Roentgenology (AJR), artificial intelligence (AI) predictive analytics performed moderately well in solving complex multifactorial operational problems - outpatient MRI appointment no-shows, especially - using a modest amount of data and basic feature engineering.
MIT researchers have developed a wireless, private way to monitor a person's sleep postures - whether snoozing on their back, stomach, or sides - using reflected radio signals from a small device mounted on a bedroom wall.
A portable, low-field magnetic resonance imaging (MRI) device can be safely used at bedside in complex clinical care settings to evaluate critically-ill patients for suspected stroke, traumatic brain injury (TBI), or other neurological problems, results of a proof-of-concept study show.
According to the Federal Statistical Office of Germany, cancer is one of the most frequent causes of death, accounting for almost 25% of all death cases. Chemotherapy is often used as a treatment, but also brings side effects for healthy organs.
Case Western Reserve University works with NYU and pharmaceutical companies Bristol Myers Squibb, AstraZeneca to validate imaging-based solutions for predicting response to therapy for lung cancer patients.
The UNC School of Medicine lab of Camille Ehre, PhD, generated high-powered microscopic images showing startlingly high SARS-CoV-2 viral loads on human respiratory surfaces, ready to spread infection in infected individuals and to others
Many diseases require IV infusion therapy. But uncontrolled infusion rates and incorrect dosing can lead to severe complications or even death. The ECGF-IS project aims to improve the safety of IV therapies in developing countries. Its goal is to develop a low-cost, electronically controlled gravity-feed infusion system to reduce the mortality associated with over-infusion and under-infusion.
Robust and widespread antibody testing has emerged as a key strategy in the fight against SARS-CoV-2, the virus responsible for the COVID-19 pandemic. However current testing methods are too inaccurate or too expensive to be feasible on a global scale. But now, scientists at the OIST have developed a rapid, reliable and low-cost antibody test.
Researchers in the COVID-19 'hot spot' in the Tyrolean region of Austria recruited consecutive coronavirus patients to their study, who were hospitalised at the University Clinic of Internal Medicine in Innsbruck, the St Vinzenz Hospital in Zams or the cardio-pulmonary rehabilitation centre in Münster, Austria. They reported on the first 86 patients enrolled between 29 April and 9 June.
Researchers at Karolinska Institutet in Sweden have identified a small neutralizing antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19. The results are published in the journal Nature Communications.
CART-I is now a CE-marked medical device This August, Sky Labs obtained a CE certificate for our ring-type medical device, CART-I. CE mark is a certification which can only be issued to products that...